Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients With Relapsing–Remitting Multiple Sclerosis: Pooled Analysis From the FREEDOMS/FREEDOMS II Trials

Neurology and Therapy - United States
doi 10.1007/s40120-019-0146-z
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Correction To: Long-Term Effect of Immediate Versus Delayed Fingolimod Treatment in Young Adult Patients With Relapsing–Remitting Multiple Sclerosis: Pooled Analysis From the FREEDOMS/FREEDOMSII Trials

Neurology and Therapy
Neurology
2020English

Long-Term Effects of Fingolimod in Multiple Sclerosis: The Randomized FREEDOMS Extension Trial

Neurology
Neurology
2015English

Long-Term Evaluation of NEDA-3 Status in Relapsing-Remitting Multiple Sclerosis Patients After Switching From Natalizumab to Fingolimod

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2018English

Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Multiple Sclerosis International
Neurology
2015English

Budget Impact Analysis of Delayed-Release Dimethylfumarate in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Long-Term Safety and Real-World Effectiveness of Fingolimod in Relapsing Multiple Sclerosis

Patient Related Outcome Measures
2017English

Fingolimod and CSF Neurofilament Light Chain Levels in Relapsing-Remitting Multiple Sclerosis

Neurology
Neurology
2015English

Cognitive Profile of Patients With Relapsing Remitting Multiple Sclerosis

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
1999English

The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy